Company intelligence / Profile preview

Citta Capital

Palo Alto, California, United Statescittacapital.com ↗

Ownership: Private
Development stage: Other

Overview

Citta Capital is an active venture capital investor focused on early-stage and growth-stage technology startups across AI/ML, big data, cloud computing, healthcare technology including medtech and biotech, IoT, SaaS/enterprise software, blockchain, robotics and more. Its portfolio features several health/med/bio-related startups such as Ordaos Bio (AI-driven protein design for pharma), SetPoint Medical (device-based therapy for autoimmune disease), among others. The firm does not conduct its own clinical trials or have its own pipeline.

Therapeutic areas: OtherImmunology
Modalities: BiologicDevice
Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships disclosed at the fund level; individual portfolio companies may have their own partnerships.

Beyond the preview

Go deeper on Citta Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citta Capital.

Explore the full profile